CARBONIC ANHYDRASE IN Plasmodium falciparum: A USEFUL TARGET FOR ANTIMALARIAL DRUG DESIGNING AND MALARIA blocking TRANSMISSION COMPOUNDS
DOI:
https://doi.org/10.17533/udea.vitae.4981Keywords:
Plasmodium falciparum, carbonic anhydrase, bicarbonate, carbon dioxide.Abstract
Carbonic anhydrase is a metalloenzyme that catalyzes the reversible conversion of CO2 to bicarbonate, anessential metabolic component used by the malaria parasites for de novo synthesis of pyrimidines and the
exflagelation of gametocytes inside the mosquito vector. Carbonic anhydrase is involved in the transport
of bicarbonate. This enzyme participates in transport of bicarbonate inside and outside the cells to avoid
an imbalance in the system CO2/HCO3- and alteration of pH in the interior of the cell as well as in the
intercellular space. Therefore, inhibition of this enzyme either in the parasite or the insect vector, could
lead to a decrease in replication and to the detriment and/or death of the parasite. Given the importance of
carbonic anhydrase in the metabolism, development and survival of Plasmodium, it could be postulated
that carbonic anhydrase inhibitors are both a therapeutic and a blocking transmission alternative. Previous
studies have demonstrated the in vitro anti-Plasmodium activity of some inhibitors. However, it is
necessary to determine their effectiveness to confirm its usefulness in the treatment or blocking malaria
transmission and the mechanism by which these inhibitors are able to affect the development of the
parasite in the mosquito vector. In this paper we present a review about the role of carbonic anhydrase in
Plasmodium spp and using some specific inhibitors as a strategy for malaria treatment and transmission
blocking strategy. Articles published in the past 59 years identified from bibliographic database (PubMed
and ScienceDirect) and papers collected by the authors were included.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright Notice and Open Access Statement
The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the Creative Commons license, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.
Authors declare that:
-
They are the intellectual property owners and are responsible for all the information stated in the article.
-
This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.
-
They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.
-
They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.
-
Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.
-
They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.
-
They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.
-
They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.
-
After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.
Conflict of interest: Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.
